ACTILITY
Actility, the industry leader in Low Power Wide Area Networks (LPWAN), and telent, a German network systems and solutions provider, have worked together to begin the roll-out of a nationwide LoRaWAN network in Germany. The network has already been deployed in Stuttgart, and roll-out to other cities continues, with national coverage expected to be complete by 2018
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161004005616/en/
The first application of the Netzikon network is already in operation. In Thuringia, sensors detect when lightning has struck the turbine blades of wind power generators. The data collected by the sensors is communicated through the LoRaWAN network and delivered to an IoT platform monitoring the wind farm, which can alert the wind farm operator, and identify potential damage more quickly, ensuring the safety and reliability of wind power plants.
The network infrastructure, powered by Actility’s ThingPark Wireless IoT solution, allows the efficient implementation of Smart City solutions, Machine-to-Machine connectivity and new digital applications. In Smart City concepts, Netzikon will offer services including remote reading of meters, acquisition of environmental data, street light control, smart parking systems or intelligent and waste management solutions. The company also envisages completely new applications which can only be realized in a cloud-capable IoT platform by combining various techniques and sensor data.
Furthermore, this new technology enables cost effective and efficient applications in the areas of asset and facility management, e.g. better supervision and maintenance of buildings, vehicles, airport facilities or railway infrastructure. The future geolocation functionality of this technology also enables tracking of assets, animals or handicapped people.
“When we set out to build a nationwide LoRaWAN network in Germany, we selected Actility as our strategic partner for building this network because of their great expertise and experience in building LoRaWAN-networks,” says Netzikon CEO Robert Blum ”We needed a carrier-grade OSS/BSS system, and Actility is the market leader for such IoT BSS/OSS software solutions. Today, Actility’s ThingPark is at the heart of carrier LoRaWAN IoT solutions across Europe, which opens up great possibilities for roaming, enabling a new class of use cases”
“We’re delighted to be working with telent to enable the Netzikon network across Germany,” says Actility CEO Mike Mulica. “Netzikon joins the rapidly growing number of national LoRaWAN networks built on our ThingPark platform, clearly demonstrating how well it meets the needs of carriers for large scale deployments. And becoming part of the global ThingPark network community means that Netzikon’s customers will be able to benefit from access to the whole ThingPark ecosystem for partners, developers and e-commerce.
About LoRaWAN™
Please see the website for more info: https://www.lora-alliance.org/
About Netzikon and telent
Netzikon GmbH is a subsidiary of telent GmbH and was founded 2016. The company offers digital services for connecting and networking intelligent devices based on LoRa ™ wireless technology. telent GmbH - a company of euromicron Group - is an independent vendor of solutions relating to networks and systems for critical infrastructure and operational and safety-related communication. The company supports its customers in design, planning, installation, integration, operation and maintenance as well as with additional, comprehensive services. telent’s customers are public authorities and companies, particularly in the rail, transport infrastructure, energy, IT and telecommunications.
About Actility & ThingPark™
Please see the website for more info: http://www.thingpark.com/en
View source version on businesswire.com: http://www.businesswire.com/news/home/20161004005616/en/
Contact:
Actility:
Anne van Gemert
anne.vangemert@actility.com
or
telent
Giuseppe
Damicis
Giuseppe.Damicis@telent.de
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline4.9.2025 07:00:00 CEST | Press release
Funding to support Phase 2b trial with MRM Health’s lead program MH002 in ulcerative colitis and advance two additional programs to IND approval Strategic partnership with Biocodex in biotherapeutics development and manufacturing adds significant non-dilutive funding in addition to the Series B financing Investment fuels expansion of proprietary CORAL® platform and pipeline MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced the successful closing of a €55 million (US$64 million) Series B financing round. The round was led by French pharmaceutical group Biocodex and included strong participation from German-based ATHOS, as well as new investor BNP Paribas Fortis Private Equity and existing investors SFPIM, Ackermans & van Haaren (AvH), OMX Europe Venture Fund (OMX), Qbic II and VIB. Validation of Leadership Position in Microbiome-Based Therapeutics Proceeds will enable MRM Heal
Abbove Unveils “Mia”: Opening a New Chapter in Digital Wealth Planning in Europe4.9.2025 06:00:00 CEST | Press release
Artificial Intelligence at the service of wealth advisors and their clients Abbove, the European platform for collaborative and family-centered wealth planning, announces today the launch of Mia, its new artificial intelligence agent. Used by more than 1,100 advisors and deployed to over 37,000 families across Europe, Abbove takes a major step forward in its mission to reimagine the wealth advisory experience in the digital age. Designed to enhance the capabilities of wealth advisors, family officers, and financial experts, Mia acts as an intelligent co-pilot. It simplifies the reading and analysis of complex estate documents, automatically extracts key information, and assists users in the understanding, enrichment, and structuring of wealth data. “The launch of Mia opens an entirely new functional AI vertical on our platform, unlocking near-infinite possibilities for future development. It’s a key milestone that brings us closer to our ambition of becoming the leading pan-European we
Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions4.9.2025 02:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies and Merck KGaA, Darmstadt, Germany, a leading science and technology company, have entered into an evaluation and option agreement to advance the development of antibody-conjugated lipid-based delivery solutions for nucleic acid payloads, such as antibody-conjugated lipid nanoparticle (LNP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903434045/en/ Under the terms of the agreement, Biocytogen will provide proprietary, fully human antibodies derived from its RenMice® platform for evaluation in Merck KGaA, Darmstadt, Germany’s antibody-conjugated LNP services. Merck KGaA, Darmstadt, Germany has been granted an exclusive option to acquire rights to selected antibody assets in return for fees and royalties on sales and su
OpZira, Inc. Launches to Advance Ophthalmic Diagnostics with Innovative Medical Device Portfolio3.9.2025 19:23:00 CEST | Press release
OpZira™, Inc., a forward-thinking ophthalmic medical device company founded on a legacy of research excellence, today announced its official formation. OpZira is dedicated to delivering innovative technologies that enhance the detection and monitoring of ocular disease, empowering clinicians with advanced diagnostic tools. OpZira’s creation follows Alcon’s acquisition of LumiThera (https://www.alcon.com/media-release/alcon-completes-acquisition-lumithera/) and its innovative Valeda® Light Delivery System, the first and only FDA-authorized treatment for dry age-related macular degeneration (AMD). As part of the transaction, LumiThera’s diagnostic product lines were spun off to LumiThera shareholders, leading to the establishment of OpZira, Inc. OpZira’s product portfolio includes: AdaptDx Pro® – A wearable dark adaptometer that leverages AI to ensure a consistent patient experience. Impaired dark adaptation speed, a key early indicator of rod-mediated dysfunction, is often among the fir
BTG Bioliquids and NanosTech Partner to Deliver End-to-End Advanced Biofuels Solution3.9.2025 18:19:00 CEST | Press release
BTG Bioliquids BV (BTL), a Netherlands-based leader in fast pyrolysis technology, and NanosTech Technology & Innovations Ltd. (NanosTech), a Canada-based catalyst development and manufacturing company, have signed a Memorandum of Understanding (MOU) to deliver a fully integrated solution to produce advanced, drop-in biofuels. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903698730/en/ The partnership combines BTL’s proven fast pyrolysis technology, which converts sustainable biomass into bio-oil, with NanosTech’s proprietary Aquaprocessing (AQP) platform, which upgrades even the most challenging bio-oils into refinery-ready feedstocks to produce fuels such as sustainable aviation fuel (SAF), renewable diesel, and marine fuels. The two companies are now actively collaborating to determine the location in Canada and Europe for the new 500-barrel-per-day modular biorefinery system. This system can be deployed near the feeds
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom